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Vascular remodeling within the aorta results in a loss of structural integrity with consequent aneurysm formation.
This degradation is more common in the abdominal aorta but also occurs above the diaphragm in the thoracic
aorta. Conventionally, the aorta has been considered a large vascular conduit with uniform cellular and extracel-
lular structure and function. Evidence is accumulating, however, to suggest that variations exist between the tho-
racic and abdominal aorta, thereby demonstrating regional heterogeneity. Further pathophysiologic studies of
aortic dilation in each of these regions have identified disparities in atherosclerotic plaque deposition, vessel me-
chanics, protease profiles, and cell-signaling pathways. Improved understanding of this spatial heterogeneity
might promote evolution in the management of aneurysm disease through computational models of aortic wall
stress, imaging of proteolytic activity, targeted pharmacologic treatment, and application of region-specific
gene therapy.
EXPERT COMMENTARYVascular remodeling within the aorta results in a loss of
structural integrity with consequent aneurysm formation.
This degradation is more common in the abdominal aorta
but also occurs above the diaphragm in the thoracic aorta.
Conservative management of small aneurysms has included
serial imaging and pharmacologic treatment of associated
risk factors while surgical intervention has been withheld
until the risk of rupture exceeded that of repair.1 Despite
these efforts, patients continue to experience significant
morbidity and mortality from ruptured aneurysms, and
therefore a great need exists for improved methods of risk
stratification, prognosis prediction, and surgical decision
making.2 Achieving this goal will require a fundamental un-
derstanding of aneurysm disease, integrating vascular phys-
iology, cell biology, and vessel mechanics as an adjunct to
the concept of aortic regional heterogeneity. The pathophys-
iology of the aorta above and below the diaphragm has dem-
onstrated disparities in atherosclerotic susceptibility, vessel
mechanics, proteolytic profiles, and cell-signaling pathways
that have implications in the development of an aortic aneu-
rysm. The objective of this review is to present literature
describing the physical and molecular characteristics of the
thoracic versus the abdominal aorta and provide evidence
supporting the hypothesis that aortic regional heterogeneity
exists. Additionally, we plan to delineate not only how these
details influence aneurysm development but also their
potential application in diverse, site-specific therapeutic
strategies.
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Aortic aneurysms remain the 13th most common cause of
death in the United States, despite advances in screening pro-
grams, imaging, and endovascular interventions.1 Demo-
graphic studies have indicated that approximately 9% of the
population older than 65 years have an abdominal aortic aneu-
rysm (AAA), but thoracic aortic aneurysms (TAAs) are far
less common, with a rate of 5.9 per 100,000 person-years.3,4
Five-year survival for TAAs has been approximated at only
64%,1 whereas a randomized prospective trial of immediate
repairversuswatchfulwaitingofAAAshas reporteda survival
rate of 75% to 80% over the 8-year study period.5 Men are
more often affected than women in both aortic regions, and
shared associated risk factors also include advanced age, cig-
arette smoking, hypertension, chronic obstructive pulmonary
disease, and coronary artery disease.4,6 Aortic atherosclerotic
plaque deposition, on the other hand, has been well docu-
mented in association with AAA growth, without a clear
cause-and-effect mechanism identified at this time.7 Although
some TAAs are associated with atherosclerotic disease, many
occur in the complete absence of plaque deposition.7 Contin-
ued investigation into disparities among patient populations
might help define TAA and AAA as unique disease entities.
The genetic contribution to aneurysm disease in the
thoracic and abdominal aorta has been a prominent and
well-studied variation. Approximately 20% of TAAs are
attributed to some form of genetic syndrome.1 Connective
tissue disorders, such as Marfan syndrome and Ehler–
Danlos syndrome type IV can affect any portion of the aorta
but preferentially cause dilation of the thoracic aorta.1 Muta-
tions of growth factor receptors have also been shown to pre-
dispose to TAA formation in both Loeys–Dietz syndrome
and familial TAA and dissection syndrome.8,9 Additionally,
the common congenital anomaly of bicuspid aortic valve has
been associated with TAA growth.10 In AAA, on the other
hand, the genetic predisposition reported in 12% to 19%
of patients with AAA has not yet been traced to particular
mutations but coincides with a family history of a first-
degree relative with aneurysm disease.11 The varyingardiovascular Surgery c Volume 136, Number 5 1123
Expert Commentary Ruddy et alcontributions of genetic and environmental influences on
TAA versus AAA development support the premise that
the 2 are unique pathophysiologic entities.
EMBRYOLOGIC HETEROGENEITY
Heterogeneity between the thoracic and abdominal aortic
regions begins during embryogenesis.12 Neural crest cell
precursors to the thoracic aorta and mesodermal ancestors
of the abdominal aorta have demonstrated unique responses
to various cytokines and growth factors. For instance, homo-
cysteine, a nonprotein amino acid that in increased levels
conveys a predisposition for cardiovascular disease, has
been shown to stimulate proliferation of neural crest–
derived vascular smooth muscle cells (SMCs), with no effect
on mesodermal SMCs.13 Also, collagen precursor produc-
tion is increased in neural crest, but not mesodermal,
SMCs after exposure to transforming growth factor
b (TGF-b).12 In addition, altered DNA synthesis12 and con-
tractile response have been reported.14 These distinct and
diverse reactions to individual stimuli, based solely on em-
bryologic origin, have highlighted the potential disparities
in aortic wall behavior observed above and below the dia-
phragm, the end result of which might manifest as aneurysm
disease.
STRUCTURAL HETEROGENEITY
The aorta is a large elastic artery composed of 3 layers: the
intima, media, and adventitia. A single layer of endothelial
cells sitting on loose connective tissue comprises the intima,
the media consists of SMCs embedded in a dense matrix of
fibrillar structural proteins, and the adventitia contains fibro-
blasts and collagen fibers. In the thoracic, as well as abdom-
inal, segments of the aorta, aneurysm formation is attributed
to degradative remodeling of the medial extracellular matrix
(ECM) and SMC loss,2 and therefore this layer of the aortic
wall will be discussed in greater detail.
The aortic media provides viscoelasticity through concen-
tric bands of elastin filaments with associated collagen fibers
and SMCs, which are termed lamellar units.15 In the mam-
malian aortic media the first 28 to 30 lamellar units from the
luminal surface do not contain a blood supply, thereby form-
ing an avascular zone that receives oxygen and nutrients by
means of transintimal diffusion from the plasma.15When ad-
ditional units are present, vasa vasorum from the adventitia
penetrate the outer media, creating a vascular zone.15 This
principle remains true in human subjects and provides a clear
distinction between the thoracic and abdominal aorta. The
thoracic aorta contains 55 to 60 lamellar units divided into
vascular and avascular zones, whereas the entirely avascular
abdominal aortic media typically contains 28 to 32 units.15
Differences in oxygen, nutrient, and growth factor delivery
to the cells of the thoracic and abdominal aortic media
likely contribute to the variations identified in vascular
remodeling.1124 The Journal of Thoracic and Cardiovascular SuInterestingly, the media has also been shown to grow dif-
ferently above and below the diaphragm. Medial thickness
increases from birth to adulthood, and in the thoracic aorta
additional lamellar units are synthesized, whereas this ex-
pansion occurs by widening each unit of the abdominal
aorta.16 The assembly of additional lamellar units might ex-
plain the increased elastin content of the thoracic aorta.17
Both of these growth mechanisms, however, maintain a con-
stant ratio of aortic diameter to medial thickness, influencing
both wall stress and tension per lamellar unit, as discussed in
the subsequent section.16 Aneurysm disease involves elastin
fragmentation and SMC death, and therefore an aortic region
with fewer lamellar units, decreased elastin content, and
poorer nutrient delivery to the SMCs, such as the abdominal
aorta, might be at considerably increased risk of medial
degeneration and aneurysm formation.
MECHANICAL HETEROGENEITY
The ultimate goal in the care of a patient with an aortic an-
eurysm is to prevent rupture, a material failure that occurs
when the aortic wall stress exceeds the tensile strength.18
The material properties of the normal and aneurysmal aorta
with regard to breaking stress and distensibility or stiffness
have been an area of intense study. According to the law
of LaPlace, wall tension is influenced by intraluminal pres-
sure, vessel diameter, and wall thickness, and the application
of this tension to a defined area indicates wall stress.19 A
consistent ratio of aortic diameter to medial thickness is
maintained throughout all mammalian species, including
the human thoracic and abdominal aortas.16 The propor-
tional change in both aortic diameter and wall thickness ob-
served above versus below the diaphragm therefore leads to
uniform wall stress in the thoracic and abdominal aortas un-
der physiologic conditions.16 As the phrase implies, the wall
stress at which rupture occurs can be called the breaking
stress,20 and similar values for breaking stress ranging
from 172  90 N/cm2 to 270  150 N/cm2 have been re-
corded in healthy thoracic and abdominal aortic regions.20,21
All tissue specimens harvested from aneurysms have had re-
duced breaking stress, but the strength of TAA samples was
roughly twice that of AAA samples (121  33 N/cm2 vs 65
 9 N/cm2, respectively),18,22 underscoring the mechanical
heterogeneity of these 2 regions.
Additionally, the abdominal aorta has fewer lamellar
units, and therefore the same wall stress absorbed by the tho-
racic aorta is dispersed across fewer units, leading to in-
creased wall tension per lamellar unit16 and subsequently
increased tension per SMC. Many studies have demon-
strated that mechanical forces can alter SMC transcriptional
activity to influence matrix structure, as well as cell sur-
vival.23 This link between mechanical force and SMC syn-
thetic activity has a potential role not only in defining the
apparent increased susceptibility of the abdominal aorta
but also in aneurysm initiation in general.rgery c November 2008
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change in pressure describes vessel distensibility, and
a lack of distensibility or resistance to deformation is re-
ferred to as stiffness.20,22 The reduced elastin content quan-
tified in the abdominal aorta17 might explain the increased
stiffness documented in this region at 569  138 N/cm2 as
opposed to 261  26 N/cm2 in the thoracic aorta.22,24 Addi-
tionally, studies comparing normal and aneurysmal aortic
tissues have consistently demonstrated increased stiffness
in both TAA and AAA specimens, potentially because of
further loss of elastin fibers and accumulation of disorga-
nized collagen.18,22,24 Continued investigation to identify
heterogeneity in the material and mechanical properties of
the walls of TAAs versus AAAs might lead to differential
prognostic profiles for these disease processes.
The stiffness of the abdominal aorta and reduced breaking
stress of the AAA wall has proved useful in aneurysm mon-
itoring. The unique material characteristics of the abdominal
aorta have been used, along with patient parameters and
3-dimensional imaging, to formulate mathematic models
of wall stress and tensile strength. Current work in AAAs
has demonstrated improved ability to predict rupture
compared with the simplified law of LaPlace and the maxi-
mal size criterion, and further application to TAAs is war-
ranted.19 As these mathematic approximations of aortic
wall stress continue to becomemore precise and the software
progressively evolves into a marketable format, surgical
intervention will rely on serial wall-stress measurements
until a known high-risk tension threshold is approached.
This value would likely vary by age, sex, and race in addi-
tion to aneurysm location. Further coupling of imaging tech-
niques to quantify proteolytic activity in conjunction with
wall stress could provide the surgeon with a comprehensive
profile of each individual aneurysm and allow for truly pa-
tient-specific surgical decision making.
HETEROGENEITY OFATHEROSCLEROTIC
PLAQUE DEPOSITION
Atherosclerosis is a chronic progressive disease of large
elastic and muscular arteries involving lipid deposition, col-
lagen production, and inflammatory cell infiltration,25 the
biochemical and molecular scope of which exceeds the
focus of this review. The disease, however, affects the aorta
differently above and below the diaphragm and has been
closely associated with aneurysm formation, and therefore
the anatomic and histologic features of aortic atherosclerotic
disease will be outlined to support the principle of regional
heterogeneity within this vessel. The Pathological Determi-
nants of Atherosclerosis in Youth study reported an
increased incidence of atherosclerotic lesions in the abdom-
inal aorta.25 The thoracic aorta appears more resistant to
plaque formation, and has demonstrated a low likelihood of
fatty streak progression.26 The fatty streaks identified in the
abdominal aorta, on the other hand, represent early athero-The Journal of Thoracic and Csclerotic lesions and have shown consistent progression to
high-grade lesions over the ensuing 10 years, presumably be-
cause of intimal thickening and increased collagen produc-
tion.26 The preferential growth of atherosclerotic plaque in
the abdominal aorta has been attributed to variations in
flow and shear stress in that region.25 Differing susceptibility
to lipid deposition and subsequent plaque evolution also sug-
gests disparate cellular and extracellular composition be-
tween the thoracic and abdominal aortas. Consequently, the
influence of atherosclerotic plaque on aneurysmal dilation
of the abdominal aorta would not be present in the thoracic
aorta, supporting a separate pathophysiologic mechanism
for TAA development. Further investigation into the link be-
tween atherosclerosis and aneurysm disease might concom-




The role of proteolysis in cardiovascular disease, includ-
ing atherosclerosis, restenosis, thrombosis, and aneurysm
formation, has been well documented.27 In particular, aneu-
rysm formation has been attributed to lysis of elastin and col-
lagen in the aortic media, thereby weakening the vessel
wall.2 The matrix metalloproteinases (MMPs), a family of
major ECM-remodeling enzymes, are responsible for angio-
genesis, wound healing, and cardiomyopathy.27 MMPs
and their antagonists, the tissue inhibitors of metalloprotei-
nases (TIMPs), are instrumental in aneurysm disease.27 A
comprehensive understanding of the activity of these en-
zymes in thoracic versus abdominal aneurysm disease
might define molecular diversity within the aortic wall and
identify divergent pathways for novel, site-specific thera-
peutic interventions.
MMPs
MMPs are divided into subclasses based on substrate spec-
ificity, such as gelatinases, elastases, and collagenases.27
Members of the gelatinase subclass, MMP-2 and MMP-9,
have demonstrated an ability to degrade denatured fibrillar
collagen (gelatin), elastin, and native types IV,V, andVII col-
lagen, along with other ECM components.28 MMP-2, or ge-
latinase A, is constitutively expressed by SMCs of the aortic
media and also displays interstitial collagenase capabilities,
cleaving type I collagen, which comprises approximately
60% of the collagen content of the aorta.28MMP-9 is also re-
ferred to as gelatinase B and can be produced by macro-
phages, fibroblasts, or SMCs that have been stimulated to
undergo a phenotypic switch favoring synthetic activity.29
The gelatinases have been heavily studied with regard to an-
eurysm formation in both the thoracic and abdominal aortas.
The contribution of MMP-2 to TAAs has been difficult to
define. Studies focusing on idiopathic TAAs have failed to
show an increase in MMP-2 levels compared with thoseardiovascular Surgery c Volume 136, Number 5 1125
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sis, on the other hand, have demonstrated increased MMP-2
activity.31 Different biochemical tests were used to quantify
MMP-2 mRNA versus active protease levels versus latent
protease levels, making comparisons between studies diffi-
cult. Also, increasing age alone has been associated with in-
creasedMMP-2 levels in the thoracic aorta, and therefore the
use of age-matched control subjects might have obscured the
effect of MMP-2 on TAAs.32 A murine model of TAA de-
velopment has reported increases in MMP-2 levels as early
as 72 hours after aneurysm induction, with return to baseline
by 2 weeks,33 suggesting a role for MMP-2 in early TAA
growth that perhaps has not been captured in human tissue
samples harvested at the time of aneurysm repair.
In AAAs the data are more definitive that MMP-2 is in-
strumental to aneurysm development. Tissue samples har-
vested at the time of aneurysm repair have consistently
shown increased MMP-2 expression and activity caused
by amplified production by native SMCs.34,35 More interest-
ingly, Freestone and colleagues35 demonstrated that aneu-
rysms smaller than 5.5 cm had greater MMP-2 activity
than larger aneurysms and proposed that early AAA growth
is directed by MMP-2. The vital role of MMP-2 in AAA for-
mation has been corroborated in a murine model of AAA in
which aneurysms could not be induced in MMP-2 knockout
mice.36
The observation that increased MMP-2 activity is re-
quired for AAA growth but might or might not influence
TAA development represents an emerging concept in aortic
heterogeneity. The differential contribution of this protein-
ase to aneurysm disease appears to vary above and below
the diaphragm, as well as within the thoracic aorta. Differ-
ences in MMP-2 levels have been reported in ascending
versus descending TAAs, a finding that strengthens the
argument for regional heterogeneity in aortic MMP produc-
tion but has not been sufficiently explored to draw any firm
conclusions. Additionally, variations in TAAMMP-2 levels
have been related to sample location because most speci-
mens are harvested from the anterior wall, but evidence
has suggested that greater MMP-2 levels can be measured
in the posterior wall of the TAA.30 The inflammatory infil-
trate accompanying atherosclerotic plaque deposition might
increase MMP-2 transcriptional activity in AAAs and ath-
erosclerotic TAAs.31 Nonatherosclerotic TAAs, on the other
hand, seem to be driven by different forces, and their effect
on thoracic aorta SMC gene expression does not include up-
regulation of MMP-2 production, supporting the premise
that multiple pathophysiologic pathways can lead to aneu-
rysm formation.
In contrast toMMP-2,MMP-9 has demonstrated a key role
in TAA disease. IncreasedMMP-9 levels have been reported
in TAAs both with and without associated atherosclerosis.31
MurineTAAmodels havedemonstrated attenuated aneurysm
growth in MMP-9 knockout mice at 4 weeks after induction1126 The Journal of Thoracic and Cardiovascular SuandMMP-9 abundance in wild-type mice beginning 2 weeks
after induction.33,37 MMP-9 levels remained increased
throughout aneurysm growth.33,37 Interestingly, immunohis-
tochemical staining has localized MMP-9 to mesenchymal
cells of the aortic media and adventitia, specifically fibro-
blasts, myofibroblasts, and SMCs that have undergone a phe-
notypic switch from purely contractile to synthetically
active.37 In the healthy aorta these cells do not produce
MMP-9, and such a shift in transcriptional activity has
previously been attributed to alterations in cell–cell and
cell–matrix interactions,29 suggesting that ECM remodeling
might precede and actually help initiate MMP-9 production
in the TAA.
MMP-9 is considered the primary elastolytic enzyme
within the AAA wall and is credited with accelerated aneu-
rysm progression. Markedly increased levels of MMP-9
have been consistently documented in AAA tissue and at-
tributed to macrophages infiltrating the aortic media and ad-
ventitia.36,38 Trends in MMP-9 expression have also been
identified with regard to aneurysm size, such that aneurysms
between 5 and 7 cm in diameter have more MMP-9 than
those either larger or smaller.39 This evidence suggests
a role for MMP-9 in aneurysm progression, perhaps to
a point at which additional proteases or hemodynamic fac-
tors become the driving force in AAA growth and rupture.39
The importance of MMP-9 in AAA development has been
further supported in a murine model in which aneurysm
induction was inhibited in MMP-9 knockout mice.36 Confir-
mation of the macrophage as the primary source of MMP-9
in AAA was achieved when MMP-9 knockout mice were
infused with wild-type macrophages and subsequent restora-
tion of AAA growth was documented.36
The different cellular sources of MMP-9 in TAAs versus
AAAs have substantiated a major point in the argument fa-
voring aortic regional heterogeneity with regard to aneurysm
disease. A hypothesis of AAA formation can be constructed
from the prevalence of atherosclerotic plaque leading to
macrophage infiltration, with consequent MMP-9 produc-
tion and surrounding matrix degradation. In contrast,
MMP-9 expression by native mesenchymal cells of the
TAA and the low incidence of inflammatory infiltrate sug-
gest that additional forces are acting in the thoracic aorta.
TIMPs
In addition to regulating MMP production and activity,
factors stimulating aortic medial degeneration also affect the
expression of TIMPs, the primary endogenous antagonists of
MMPs. Aortic SMCs constitutively express TIMP-1 and
TIMP-2, and TIMP-1 has been demonstrated to inhibit
most MMPs, especially MMP-9,27 but the function of
TIMP-2 is more complex. Although it can inhibit MMP-2
and MMP-9, TIMP-2 is also a component of the MMP-2
activation complex.40 The specific relationship between
TIMPs and aneurysm disease has not yet been defined,rgery c November 2008
Ruddy et al Expert Commentarybut variability between TAAs and AAAs has become
apparent.
The interplay of MMPs and TIMPs directs ECM turnover
in healthy tissues, and the degradation associated with aneu-
rysm growth in any location can be expected to stem from an
alteration favoring proteolysis. More specifically, the ratio of
MMP-9 to TIMP-1 has been used to estimate the proteolytic
index of the ECM.38 In TAAs TIMP-1 levels have been de-
creased or unchanged from healthy aortic tissue, and there-
fore coupled with the increased MMP-9 levels, a large shift
in the proteolytic state favoring ECM degeneration has
been noted.31,41 AAA tissue samples, on the other hand,
have demonstrated increased levels of TIMP-1 compared
with those seen in control aortic specimens.38 Despite this
amplified TIMP-1 production, the MMP-9/TIMP-1 ratio
has favored proteolysis in AAAs because MMP-9 levels
have been increased to a much greater extent.38 The differen-
tial role of TIMP-1 in this proteolytic shift supports the con-
cept of disparate stimuli andmechanisms for aortic dilation in
the thoracic and abdominal aortas.
The contribution of TIMP-2 to aneurysm development
has been obscured by its dual role in activating, as well as
inhibiting, MMP-2.40 Additionally, no consistent trend in
TIMP-2 expression has been identified in either TAA or
AAA samples, further complicating the issue.31,38,41 This
variability can be largely attributed to the assorted biochem-
ical techniques used to quantify TIMP-2 expression, abun-
dance, or activity in each report. A few studies have
evaluated a second proteolytic index defined as the ratio of
MMP-2 to TIMP-2.31,34,38 In TAA specimens an increase
in the MMP-2/TIMP-2 ratio has been observed,31 whereas
that of AAA samples has remained unchanged from ratios
seen in control aortic tissue.38 Therefore pertaining to
TIMP-2, the SMC transcriptional response to aneurysm-
initiating stimuli has appeared to differ in the thoracic and
abdominal aortas, potentially because of alternate causative
factors, cell signaling, or proteolytic substrates.
Ideally, the identification and definition of proteolytic
variations between the TAA and the AAA will allow site-
specific, minimally invasive interventions directed at slow-
ing or halting aneurysm growth. General MMP inhibition
is currently being explored,27 but the use of gene therapy
through systemic introduction or regional placement with
endostents to preferentially affect particular MMPs might
narrow the potential side effect profile. For instance, target-
ing MMP-2 activity in small AAAs versus MMP-9 in ad-
vanced disease might be a useful stratification. In TAAs,
on the other hand, MMP-9 inhibition could be beneficial,
despite the degree of aortic dilation. More importantly,
methods of quantifying MMP or TIMP activity might prove
useful in surgical planning. Technetium-tagged small mole-
cules that preferentially enter the vascular media and bind
MMPs can be coupled with nuclear imaging to identify
patients with increased proteolytic activity, signifying aThe Journal of Thoracic and Cpropensity for rapid expansion and rupture. These patients
might warrant urgent repair, despite their current aneurysm
diameter. As mentioned earlier, the combination of compu-




Many investigators have focused on characterizing the
protease systems responsible for aortic medial degeneration,
and the signaling pathways initiating protease production re-
main poorly understood. The regulation of aortic SMC gene
expression through cytokines and growth factors has been
suspected to be a major contributor to aneurysm growth.2
Cytokines are intercellular mediators that direct the immune
response to various stimuli, and a subfamily of cytokines,
the chemokines, specifically act as potent chemoattractants
and activators of leukocytes. The peptide growth factor
TGF-b encompasses a large family of messengers impli-
cated in numerous cellular pathways, including angiogene-
sis, apoptosis, and tissue fibrosis.42 This growth factor can
also maintain normal blood vessel morphology through
stimulation of ECM production and inhibition of inflamma-
tory mediators.42 Although not fully explored, current evi-
dence suggests that the signaling pathways driven by
cytokines and TGF-b differentially affect aneurysm growth
in the thoracic and abdominal aorta.
IMMUNE MEDIATORS
The presence and nature of the aneurysm wall inflamma-
tory infiltrate can be considered a major defining factor in the
argument favoring regional aortic heterogeneity. Levels of
certain cytokines, such as tumor necrosis factor a, interleu-
kin 1b, and interleukin 6, have been universally increased in
both TAA and AAA tissue samples,43,44 presumably related
to previous evidence that these cytokines augment MMP ex-
pression.45 The inflammatory infiltrate described in the me-
dia and adventitia of aneurysm walls has been dominated
by CD4þ T-helper lymphocytes and macrophages.44 These
lymphocytes can produce a proinflammatory or anti-inflam-
matory cytokine profile, classifying themselves as TH1 or
TH2 cells, respectively, and whether one subgroup preferen-
tially drives medial degeneration has important implications.
In a TAA the presence of an inflammatory infiltrate has been
a controversial issue. One particularly influential study
examining TAA tissue described categories of infiltrated
versus noninfiltrated aneurysms and further reported
a TH1-driven immune response.
46 The increased levels of in-
terferon g correlated with aneurysm diameter, intimal thick-
ness, and elastin fragmentation.46 AAA specimens have
demonstrated increased expression of many proinflamma-
tory and anti-inflammatory cytokines, and studies aimed at
defining the lymphocytic infiltrate as predominantly TH1
or TH2 have found evidence of both.
47,48 Collectively, theardiovascular Surgery c Volume 136, Number 5 1127
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Variable Thoracic aorta Abdominal aorta References
Epidemiology Rare aneurysm site Most common aneurysm site 1–11
20% caused by genetic syndromes 20% have familial predisposition
Embryology Derived from neural crest Derived from mesoderm 12–14
Structure Vascular outer media Avascular medial layer 15–17
More numerous lamellar units Fewer lamellar units
Grows by synthesizing additional lamellar units Grows by increasing lamellar unit thickness
Greater elastin and collagen content Lower elastin and collagen content
Mechanics Greater distensibility Increased stiffness 18–24
TAA breaking stress greater than AAA breaking
stress
AAA breaking stress less than TAA breaking
stress
Increased tension per lamellar unit
Atherosclerosis Low likelihood of lesion progression from fatty
streak to atheroma
Site of most severe atherosclerosis 25–26
High likelihood of lesion progression from fatty
streak to atheroma
MMPs Inconsistent role for MMP-2 Early aneurysm growth driven by MMP-2 27–39
MMP-9 produced by synthetically active SMCs
and fibroblasts
MMP-9 produced by macrophages
Lack of MMP-9 attenuated aneurysm
development
MMP-9 proportional to aneurysm diameter
Lack of MMP-9 prevented aneurysm
development
TIMPs No change or decreased TIMP-1 Increased TIMP-1 27–41
MMP-2/TIMP-2 ratio increased MMP-2/TIMP-2 ratio unchanged
Immune mediators TH1-type immune response in infiltrated
aneurysms
Evidence of both proinflammatory and
anti-inflammatory cytokines
43–48
TGF-b response Increased signaling contributes to aneurysm
disease
Overexpression attenuated proteolytic state 49–50
TAA, Thoracic aortic aneurysm; AAA, abdominal aortic aneurysm; MMP, Matrix metalloproteinase; SMC, smooth muscle cell; TIMP, tissue inhibitor of metalloproteinase.data on immunologic mediators have suggested that the ini-
tiation and growth of an infiltrated TAA is driven by proin-
flammatory cytokines, whereas AAA development involves
a complex interaction between opposing immunologic path-
ways, ultimately supporting heterogeneity in the pathophys-
iology of aortic aneurysm formation.
TGF-b
Alterations in TGF-b expression, activation, or receptor
activity might provide pathways toward aortic wall degener-
ation. TGF-b is associated with the ECM microfibrils in the
thoracic and abdominal aortas, and the concentration of this
ligand has demonstrated tight regulation.49 A murine model
of Marfan syndrome has described increased levels of bio-
logically active TGF-b in these animals and a correlation
to TAA growth.49 Additionally, TGF-b receptor mutations
have been identified as the cause of the familial TAA and
dissection and Loeys–Dietz syndromes, in which currently
unidentified mechanisms have allowed enhanced TGF-b
signaling and TAA formation.8,9 In the abdominal aorta
the opposite might be true. Evidence has suggested that en-
zymatic activity of MMP-2 and MMP-9 release TGF-b,49
the overexpression of which can then decrease gelatinase1128 The Journal of Thoracic and Cardiovascular Suand increase TIMP production, potentially attenuating aneu-
rysm development.50 Although not fully characterized, the
role of TGF-b in TAAs versus AAAs has demonstrated
divergence, likely because of the disparate embryologic or-
igins of the thoracic and abdominal aortas discussed earlier,
and this represents yet another example of heterogeneity in
aneurysm disease.
Modification of upstream signaling pathways might rep-
resent a viable approach to disrupting aneurysm growth.
AAAs appear to be influenced by both proinflammatory
and anti-inflammatory mediators, whereas a subset of
TAAs are driven solely by cytokines released from TH1-
type lymphocytes. Additionally, TGF-b overexpression in
AAAs and inhibition in TAAs might halt aneurysm progres-
sion. Systemic upregulation or blockade of these messengers
would likely be detrimental to a patient’s overall health, and
therefore the use of directed gene therapy or regional appli-
cation would be required. A rodent AAA model involved
endostent-delivered gene therapy with TGF-b and demon-
strated a halt in aneurysm growth.50 Similarly, delivered
blockade of interferon g in infiltrated TAAs might also
have the potential to alter the extracellular milieu and stabi-
lize the aortic wall. Further defining the molecular variancesrgery c November 2008
Ruddy et al Expert Commentaryamong TAA and AAA could aide in the development of tar-
get-specific and region-specific minimally invasive aneu-
rysm therapy.
CONCLUSIONS
An array of genetic, anatomic, biochemical, and mechan-
ical factors have been recognized as contributors to aortic
aneurysm disease, and a comprehensive model incorporat-
ing all these forces has yet to emerge. The hypothesis that
heterogeneity exists within the aorta further complicates
the study of this disease process. Variations among vessel
mechanics, atherosclerotic plaque deposition, protease pro-
files, and cell-signaling pathways have been identified
(Table 1). This review has sought to define and explore dis-
parate properties in the thoracic and abdominal aortic seg-
ments as they pertain to aneurysm development (Figure 1)
and furthermore to suggest how these variations can be ex-
ploited to advance current management of aortic aneurysm
disease. Additional research into these regional distinctions
is expected to uncover novel dynamic imaging and therapeu-
tic options.
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